Abstract: This present invention discloses a heterocyclic substituted acardite derivate and application thereof, namely compounds in the general formula (1) or the general formula (2) or pharmaceutically acceptable salts thereof, wherein A is monosubstituted or polysubstituted quinoline, isoquinoline, quinazoline, pyrrole or pyrimidine, and the substituent is halogen, C1-5alkyl, C1-5haloalkyl, C1-5alkoxy, C1-5haloalkoxy, C1-5alkylamino, C1-5haloalkylamino, amino or nitryl; R1 is C1-5alkyl; R2 is one or more selected from hydrogen, halogen, alkyl, alkoxy, haloalkyl or haloalkoxy; and R3 is one or more selected from hydrogen, halogen, alkyl, alkoxy, haloalkyl or haloalkoxy. The compound of the present invention and the pharmaceutically acceptable salt thereof can be used for treating tumor or leukemia.

Abstract: An electromagnetic ultrasonic transducer and an array thereof are provided. This electromagnetic ultrasonic transducer includes a support, an elastic board disposed on the support, a magnetizer on the elastic board, and a magnet field generator for vibrating the magnetizer, wherein, the thickness of the magnetizer is of the order of microns. The thickness of the elastic board is also of the order of microns. This electromagnetic ultrasonic transducer is able to produce acoustic waves of high frequency, which are useful for ultrasonic therapy.

Abstract: The invention features 4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs, compositions containing them, and methods of using them as PPAR delta modulators to treat or inhibit the progression of, for example, dyslipidemia.

Abstract: The present invention discloses a composite material comprising: a substrate with an anodic oxide film layer having micropores; and at least one kind of dye filled in the micropores, wherein amount of the same kind of dye is gradient distribution on at least part of the substrate. The composite material has an even, metal gloss, uneasily scratched and wore out surface with gradually changed color. Moreover, the present invention also provided a method of preparing the same.

Abstract: A method comprising providing a halogen stream; providing a first alkane stream; reacting at least a portion of the halogen stream with at least a portion of the first alkane stream to form a halogenated stream, wherein the halogenated stream comprises alkyl monohalides, alkyl polyhalides, and a hydrogen halide; providing a second alkane stream; and reacting at least a portion of the second alkane stream with at least a portion of the alkyl polyhalides to create at least some additional alkyl monohalides.

Abstract: A processing apparatus for semiconductor work pieces and related methodology is disclosed and which includes a processing chamber having an internal cavity, and which has a plurality of rotatable processing stations positioned therein and wherein the rotatable processing stations each process a semiconductor work piece.

Abstract: The invention features 4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs, compositions containing them, and methods of using them as PPAR delta modulators to treat or inhibit the progression of, for example, dyslipidemia.

Abstract: One exemplary embodiment includes a cast alloy including Al present in an amount of about 6.5 wt % to about 9.0 wt %; Sn present in an amount of about 1.0 wt % to about 3.0 wt %; Ce present in an amount of about 0 wt % to about 1.0 wt %; and, Mg comprising a balance of the alloy minus an amount of minor and trace elements wherein Mg is present at an amount of greater than about 85 wt %.

Abstract: A method comprising providing a halogen stream; providing a first alkane stream; reacting at least a portion of the halogen stream with at least a portion of the first alkane stream to form a halogenated stream, wherein the halogenated stream comprises alkyl monohalides, alkyl polyhalides, and a hydrogen halide; providing a second alkane stream; and reacting at least a portion of the second alkane stream with at least a portion of the alkyl polyhalides to create at least some additional alkyl monohalides.

Abstract: One embodiment includes a wheel including a first portion including magnesium, the first portion including at least a rim; a second portion including aluminum; and an interface where the first portion and the second portion contact each other.

Abstract: A method for preparing nylon microspheres is provided, said method comprising steps (1), (2) and (3) or steps (1?), (2) and (3) as follows: (1) a radically polymerizable monomer is dispersed in a molten lactam monomer, and a free radical initiator is added, so that radical polymerization of the radically polymerizable monomer is carried out, to give a mixture of a free radical polymer and the lactam monomer; or (1?) a mixture of a free radical polymer and a molten lactam monomer is provided; and (2) an initiator and an activator, used for anionic ring-opening polymerization of the lactam monomer, are added to the mixture obtained in step (1) wherein the remaining radically polymerizable monomer and water are removed, or to the mixture obtained in step (1?), so that the anionic ring-opening polymerization of the lactam is carried out to give a polymer alloy of the free radical polymer/polyamide; and (3) the free radical polymer in the polymer alloy obtained in step (2) is removed by dissolution, giving nylon m

Abstract: The grain size of magnesium alloys is effectively refined and made smaller by the addition of a small amount of titanium. The effect of the reduction of grain size is often an improvement in the strength and processability of a cast magnesium alloy. Often less than about 0.1% by weight of titanium need be used. It may be preferred to incorporate the titanium with another alloying constituent (such as aluminum) for addition to a melt of a magnesium base alloy.

Abstract: The invention is directed to compounds of Formula (I) described herein useful as CETP inhibitors, compositions containing them, and methods of using them.

Abstract: The invention features 4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs, compositions containing them, and methods of using them as PPAR delta modulators to treat or inhibit the progression of, for example, dyslipidemia.

Abstract: The invention relates to a method for setting a CRBT, including: initiating a call to a called terminal and receiving a CRBT sent from a CBC, by a calling terminal in a communication network; during the process of playing the CRBT or the communication process or after the call is ended, authenticating the calling terminal by the communication network in response to a CRBT setting request message sent by the calling terminal or the called terminal actively or upon an inquiry, so as to judge whether the calling terminal activated a CRBT service; if it is judged that the calling terminal has not activated a CRBT service, sending, by the communication network, a CRBT service activation message to the calling terminal to instruct the calling terminal to subscribe the CRBT service, and then subscribing, by the calling terminal, the CRBT service through a response to the message; and if it is judged the calling terminal already activated the CRBT service, or the CRBT service is activated by the calling terminal resp

Abstract: The invention provides DNA compositions that relate to transgenic insect resistant maize plants. Also provided are assays for detecting the presence of the maize TC1507 event based on the DNA sequence of the recombinant construct inserted into the maize genome and the DNA sequences flanking the insertion site. Kits and conditions useful in conducting the assays are provided.

Abstract: A method of forming a silicon nitride layer is described. According to the present invention, a silicon nitride layer is deposited by thermally decomposing a silicon/nitrogen containing source gas or a silicon containing source gas and a nitrogen containing source gas at low deposition temperatures (e.g., less than 550° C.) to form a silicon nitride layer. The thermally deposited silicon nitride layer is then treated with hydrogen radicals to form a treated silicon nitride layer.

Abstract: Methods of extruding magnesium-based casting alloys are provided. The magnesium alloys have relatively high strength and castibility, as well as an improved ductility and extrudability for wrought alloy applications. The magnesium-based wrought alloy comprises aluminum (Al) of between about 2.5 to about 3.5 wt. %, manganese (Mn) of less than about 0.6 wt. %, zinc (Zn) of less than about 0.22 wt. %, other impurities of less than about 0.1 wt. %, and a balance of magnesium (Mg). The disclosure provides various methods of forming extruded structural components, including automotive components, and methods of forming such wrought alloys.

Abstract: A method includes determining a first performance indicator for a wireless network, the first performance indicator including an unperturbed value of a parameter of an access point of the network; perturbing the parameter of the wireless network by a predetermined increment to obtain a perturbed value of the parameter; determining a second performance indicator for the wireless network, the second performance indicator including the perturbed value of the parameter; and selecting the one of the unperturbed value of the parameter and the perturbed value of the parameter corresponding to a higher of the first performance indicator and the second performance indicator.

Abstract: The invention relates to IL-1O Receptor alpha (IL-1OR?) antibodies and subsequences thereof, human and humanized IL-10 Receptor alpha (IL-IOR?) antibodies and subsequences thereof, isolated and purified IL-10 Receptor alpha (IL-1OR?) antibodies and subsequences thereof, compositions including IL-10 Receptor alpha (IL-1OR?) antibodies and subsequences thereof, and methods that employ IL-10 Receptor alpha (IL-1OR?) antibodies and subsequences thereof. The invention includes among other things, methods of treating a pathogen infection, pathogen reactivation, and methods of vaccinating or immunizing against a pathogen infection, which include, for example, administering an IL-10 Receptor alpha (IL-1OR?) antibody or subsequence, to treat a pathogen infection, pathogen reactivation or for vaccination or immunization.